What is it about?
Molecular response to tyrosine kinase inhibitors
Featured Image
Perspectives
Assessment of MRD and prediction of TFR in CML patients in the area of TKI
Professor-MD/PhD Rim FRIKHA
Faculty of Medicine at Sfax's University
Read the Original
This page is a summary of: Assessment of molecular response to tyrosine kinase inhibitors in Tunisian Patients with Chronic Myeloid Leukemia, Journal of Oncology Pharmacy Practice, November 2021, SAGE Publications,
DOI: 10.1177/10781552211048232.
You can read the full text:
Contributors
The following have contributed to this page
